Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000145768 | SCV000192896 | uncertain significance | Rubinstein-Taybi syndrome due to CREBBP mutations | 2014-01-23 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000177560 | SCV000229446 | uncertain significance | not provided | 2015-04-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000177560 | SCV000968604 | benign | not provided | 2020-03-23 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001087896 | SCV001019370 | likely benign | Rubinstein-Taybi syndrome | 2024-01-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002354332 | SCV002653411 | likely benign | Inborn genetic diseases | 2017-10-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000177560 | SCV004144966 | benign | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | CREBBP: PP2, BS1, BS2 |
Prevention |
RCV003935243 | SCV004754238 | likely benign | CREBBP-related condition | 2021-07-16 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Practice for Gait Abnormalities, |
RCV002221200 | SCV002498707 | likely pathogenic | Tip-toe gait | no assertion criteria provided | clinical testing |